Charles Schwab Investment Management Inc. Acquires 9,990 Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO)
Charles Schwab Investment Management Inc. raised its stake in shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) by 0.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,188,838 shares of the company’s stock after acquiring an additional 9,990 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Allogene Therapeutics […]
Charles Schwab Investment Management Inc. raised its stake in shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) by 0.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,188,838 shares of the company’s stock after acquiring an additional 9,990 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Allogene Therapeutics […]
